Methods of tagging rna molecules associated with epigenetically modified chromatin in living cells
Abstract
A method of tagging RNA molecules involved in an epigenetically modified chromatin in real-time in living cells is provided. The method involves the introduction of an epigenetic reader module protein, an engineered ascorbate peroxidase, and a biotin-aniline probe into a living cell. Subsequently, the biotin-aniline probe is oxidized by the engineered ascorbate peroxidase, resulting in the formation of a covalent bond between the probe and an RNA molecule within the epigenetically modified chromatin, thereby generating a biotin-tagged RNA molecule. Finally, the biotin-tagged RNA molecule is purified for subsequent sequencing analysis.
Claims
exact text as granted — not AI-modified1 . A method of tagging RNA molecules involved in an epigenetically modified chromatin in real-time in living cells, comprising:
introducing an epigenetic reader module protein, an engineered ascorbate peroxidase and biotin-aniline probe into a living cell; oxidizing the biotin-aniline probe by the engineered ascorbate peroxidase and forming a covalent bond between the biotin-aniline probe and an RNA molecule of an epigenetically modified chromatin to obtain a biotin-tagged RNA molecule; and purifying the biotin-tagged RNA molecule for further sequencing.
2 . The method of claim 1 , wherein the epigenetic reader module protein locates a location of the epigenetically modified chromatin and drags the engineered ascorbate peroxidase to the location.
3 . The method of claim 1 , wherein the oxidation of the biotin-aniline probe occurs when the engineered ascorbate peroxidase is exposed to H 2 O 2 .
4 . The method of claim 1 , wherein the epigenetic reader module protein is an evolutionarily conserved protein derived from natural proteins.
5 . The method of claim 4 , wherein the epigenetic reader module protein comprises chromodomain from CBX7 or Drosophila Polycomb (dPC) for H3K27me3 (trimethyl-histone H3 lysine 27), chromodomain from CBX1 for H3K9me3 (trimethyl-histone H3 lysine 9), and PHD domain from TAF3 for H3K4me3.
6 . The method of claim 4 , wherein the epigenetic reader module is further fused with a plurality of a repetitive peptide epitope and the engineered ascorbate peroxidase is fused with a single-chain variable fragment (scFv).
7 . The method of claim 6 , wherein the repetitive peptide epitope is recognizable by the scFV for recruiting the engineered ascorbate peroxidase.
8 . The method of claim 7 , wherein the repetitive peptide epitope has an amino acid sequence of SEQ ID NO:01 and the scFV has an amino acid sequence of SEQ ID NO:02.
9 . A kit for tagging RNA molecules involved in an epigenetically modified chromatin in real-time in living cells, comprising:
an epigenetic reader module protein; an engineered ascorbate peroxidase; and a biotin-aniline probe.
10 . The kit of claim 9 , wherein the components of the kit are directly delivered into a living cell.
11 . The kit of claim 9 , wherein the engineered ascorbate peroxidase oxidizes the biotin-aniline probe when the engineered ascorbate peroxidase is exposed to H 2 O 2 .
12 . The kit of claim 11 , wherein the oxidized biotin-aniline probe forms a covalent bond to an RNA molecule of an epigenetically modified chromatin to generate a biotin-tagged RNA molecule.
13 . The kit of claim 12 , wherein the biotin-tagged RNA molecule is further purified and enriched.
14 . The kit of claim 9 , wherein the epigenetic reader module protein locates a location of the epigenetically modified chromatin and drags the engineered ascorbate peroxidase to the location.
15 . The kit of claim 9 , wherein the epigenetic reader module protein is an evolutionarily conserved protein derived from natural proteins.
16 . The kit of claim 9 , wherein the epigenetic reader module protein comprises chromodomain from CBX7 or dPC for H3K27me3, chromodomain from CBX1 for H3K9me3, and PHD domain from TAF3 for H3K4me3.
17 . The kit of claim 9 , wherein the epigenetic reader modules is further fused with a plurality of a repetitive peptide epitope and the engineered ascorbate peroxidase is fused with a scFv.
18 . The kit of claim 17 , wherein the repetitive peptide epitope is recognizable by the scFV for recruiting the engineered ascorbate peroxidase.
19 . The kit of claim 18 , wherein the repetitive peptide epitope has an amino acid sequence of SEQ ID NO:01 and the scFV has an amino acid sequence of SEQ ID NO:02.Join the waitlist — get patent alerts
Track US2025333785A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.